Artificial Womb Facility Market
Artificial Womb Facility Market to Reach $10 Billion by 2028
?[London, United Kingdom] – [1st June 2023] – The artificial womb facility market is expected to reach $10 billion by 2030, according to a new report by Pharmanucleus. The market is being driven by the increasing demand for assisted reproductive technologies (ART) and the growing number of premature births.
Artificial wombs, also known as ectogenesis, are devices that can support the development of a fetus outside the womb. They are typically used to help premature babies survive, but they could also be used to help women who are unable to carry a pregnancy to term.
The artificial womb market is still in its early stages, but it is expected to grow rapidly in the coming years. This is due to the increasing demand for ART and the growing number of premature births.
In the United States, the number of ART procedures performed each year has increased by more than 50% in the past decade. This is due to the increasing number of women who are delaying childbirth and the growing number of couples who are struggling to conceive.
The number of premature births in the United States has also increased in recent years. This is due to a number of factors, including the increasing age of mothers, the obesity epidemic, and the use of assisted reproductive technologies.
Artificial wombs could help to reduce the number of premature deaths and the long-term health problems that can be caused by premature birth. They could also help to improve the chances of survival for babies who are born with life-threatening conditions.
The artificial womb market is expected to be driven by the following factors:
-
The increasing demand for ART
-
The growing number of premature births
-
The development of new artificial womb technologies
-
The increasing acceptance of artificial wombs by the public
The artificial womb market is expected to face the following challenges:
-
The high cost of artificial wombs
-
The ethical concerns surrounding the use of artificial wombs
-
The lack of regulatory oversight for artificial wombs
Despite these challenges, the artificial womb market is expected to grow rapidly in the coming years. This is due to the potential benefits of artificial wombs for premature babies and the increasing demand for ART.
For more information about the report and to request a sample copy, please visit?
?
Contact Us:
John.M
Business Consultant
john.m@pharmanucleus.com
Support: +44 (0)20 8470 4967
https://www.pharmanucleus.com/
About Pharmanucleus
Pharma Nucleus is a market research company that provides clients access to custom, syndicated reports and consulting on one platform. As a company with rich knowledge in analysis and research across healthcare domains, such as pharma, medical device and biotechnology. Insights derived from Pharma Nucleus help life sciences and other healthcare organizations accelerate the launch, development, and dissemination of life-saving therapies, navigate significant attention with key opinion leaders, and help ensure equitable access to healthcare services.?